On 25 November, our CEO Victoria Clare delivered a speech at the All-Party Parliamentary Group on Women’s Health urging the policymakers and MPs present to be ambitious and to set meaningful targets that will improve outcomes for ovarian cancer in the UK. The launch of this report in the Houses of Parliament was an important opportunity to amplify the voices and experiences the Ovacome community. 

Most recent statistics indicate that approximately 4 out of 10 women diagnosed with ovarian cancer in England in 2022 and Wales in 2023 had an emergency admission within 28 days prior to their diagnosis. Only 74% of those diagnosed with stage 2, 3 or 4 (or unstaged) ovarian cancer received any treatment in England in 2022 with statistics slightsly increasing to 80% for Wales in 2023. Though the State of the nation report did not include statistics in Scotland or Northern Ireland, we know that patients throughout the UK  would benefit from the same recommendations.